Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
NCT ID:
NCT02023905
Group ID:
EG000
Title:
Arm 1: Everolimus
Description:
If the tumor is 1p/19q intact, then patients will be further selected by whether or not their tumor demonstrates activation of the PI3K/mTOR pathway. If activation is present, patients will be treated with single-agent everolimus at 10 mg daily continuously for up to 24 cycles.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
16
Other Number Affected:
12
Other Number At Risk:
16
Study:
NCT02023905
Results Section:
NCT02023905
Adverse Events Module:
NCT02023905